OCX - Oncocyte Corp - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - In Vitro & In Vivo Diagnostic Substances - OCX (1642380)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

17 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2021-03-19
OCXAndrews Ronald AsburyCEOP - Purchase$4.79+11,000113,698+11%+$52,702
2021-02-05
OCXBroadwood Partners, L.P.10%P - Purchase$4.50+600,00033,556,113+2%+$2,700,000
2021-01-20
OCXBroadwood Partners, L.P.10%P - Purchase$3.42+1,460,28032,356,113+5%+$4,999,999
D
2020-12-23
OCXKingsley Alfred DDirS - Sale+OE$2.55-900478,2230%-$2,295
DM
2020-12-21
OCXKingsley Alfred DDirS - Sale+OE$0.31-42,800412,615-9%-$13,076
A
2019-09-12
OCXLevine Mitchell SCFOP - Purchase$2.01+10,00013,495+286%+$20,060
A
2020-09-12
OCXLevine Mitchell SCFOP - Purchase$2.01+10,00013,495+286%+$20,060
2020-08-03
OCXParker Albert PCOOP - Purchase$1.33+5,0005,000New+$6,648
2020-08-03
OCXKalajian Tony TSr.VP, Chief Accounting OfficeP - Purchase$1.31+5,00015,000+50%+$6,533
2020-08-03
OCXAndrews Ronald AsburyCEOP - Purchase$1.35+40,000102,698+64%+$53,880
2020-08-03
OCXLevine Mitchell SCFOP - Purchase$1.32+10,00036,579+38%+$13,200
2020-04-24
OCXBroadwood Partners, L.P.10%P - Purchase$2.27+1,050,00029,435,553+4%+$2,383,500
AM
2020-03-30
OCXAndrews Ronald AsburyCEO, PresP - Purchase$2.30+45,21662,698+259%+$104,150
EM
2020-03-30
OCXAndrews Ronald AsburyCEO, PresP - Purchase$1.41+45,21662,698+259%+$63,826
2020-01-02
OCXBroadwood Partners, L.P.10%P - Purchase$2.16+1,391,46627,335,553+5%+$3,000,001
2020-01-02
OCXLineage Cell Therapeutics, Inc.Previous 10% OwnerS - Sale$2.16-2,383,0906,041,154-28%-$5,137,942
2019-11-13
OCXBroadwood Partners, L.P.10%P - Purchase$1.70+1,176,47124,552,621+5%+$2,000,001

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top